Explorer
Debate: Experts share key points after vaccine approval
Drug Controller General of India (DCGI) V.G. Somani on Sunday approved Serum Institute of India's 'Covishield' vaccine and Bharat Biotech's 'Covaxin' for emergency use.
Pune-based Serum Institute of India has partnered with Oxford-AstraZeneca for conducting clinical trials and manufacturing 'Covishield', while Bharat Biotech has collaborated with the Indian Council of Medical Research (ICMR) for 'Covaxin'.
Serum and Bharat Biotech Pfizer had applied for the accelerated approval on December 6 and 7, respectively.
Pune-based Serum Institute of India has partnered with Oxford-AstraZeneca for conducting clinical trials and manufacturing 'Covishield', while Bharat Biotech has collaborated with the Indian Council of Medical Research (ICMR) for 'Covaxin'.
Serum and Bharat Biotech Pfizer had applied for the accelerated approval on December 6 and 7, respectively.
India
Politics: Yogi Adityanath's Remarks on Riots Trigger Political War Ahead of UP Elections
Madhya Pradesh: Police End Cheeta Protest in Madhya Pradesh's Chhatarpur
Monsoon Crisis: Heavy Monsoon Rains Trigger Floods and Landslides Across Northern Himalayan States
Weather & Public Safety: Heavy Rains Raise Flood Fears in Himachal, Viral Videos Highlight Dangerous Public Negligence
Parliament: Delimitation Emerges as Key Flashpoint Ahead of Parliament's Monsoon Session
View More
Trending News




















